Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study June 2025 Congress News Read more
2021 May Covid-19 BSTH’s President Cecile Oury advocates continuing vaccination with AstraZeneca vaccine Read more
2021 May Covid-19 CHALLENGES AND LESSONS LEARNED IN THE MANAGEMENT OF MULTIPLE MYELOMA IN THE SETTING OF COVID-1... Read more
2021 March Clinical practice World first: Dutch hospitals start trial with redistribution leftover cancer drugs Read more
2021 March Viewpoints European thalassaemia patients share their everyday challenges in special video Read more
2021 February Medical Research Green tea compound could be gateway towards new cancer drugs Read more
Top
